ReShape Lifesciences (Formally known as EnteroMedics)

280 articles about ReShape Lifesciences (Formally known as EnteroMedics)

• EnteroMedics to Present at Craig-Hallum 3rd Annual Alpha Select Conference

  9/20/2012

• EnteroMedics to Participate in the Lazard Capital Markets Third Annual Medical Technology 1x1 Corporate Access Day

  9/12/2012

• Medical Tool to Switch Off Hunger Pangs, EnteroMedics Reveals

  8/24/2012

• EnteroMedics Reports Second Quarter 2012 Financial Results

  8/7/2012

• EnteroMedics to Present at 32nd Annual Canaccord Genuity Growth Conference

  8/6/2012

• EnteroMedics Reports Exercise of 1,653,635 Common Stock Warrants

  7/13/2012

• EnteroMedics to Present at Seventh Annual JMP Securities Healthcare Conference

  7/9/2012

• EnteroMedics Added to Russell 3000(R) and Russell 2000(R) Indexes

  6/25/2012

• EnteroMedics Announces First Commercial Implants of the Maestro(R) Rechargeable System

  6/5/2012

• EnteroMedics to Present at the 9th Annual Craig-Hallum Institutional Investor Conference

  5/29/2012

• EnteroMedics Reports First Quarter 2012 Financial Results

  4/24/2012

• EnteroMedics to Host First Quarter 2012 Financial Results Conference Call and Provide Business Update

  4/19/2012

• EnteroMedics Strengthens Financial Position With $20 Million Debt Agreement and $5.0 Million Equity Offering

  4/17/2012

• Obesity Treatment Firm, EnteroMedics, Begins Commercializing Neurostimulation Device

  4/6/2012

• EnteroMedics Announces First Commercial Shipment of the Maestro(R) Rechargeable System to Australia

  4/3/2012

• EnteroMedics Announces 2.5-Year Diabetes, Hypertension and Weight Loss Data From the Maestro(R) RC System DM2 ENABLE Study

  4/3/2012

• Big Executive Pay Raises at EnteroMedics a Year After They Took Significant Cuts

  3/22/2012

• EnteroMedics Release: American Medical Association Adopts New Category III CPT Codes for Vagus Nerve Blocking Therapy

  3/12/2012

• EnteroMedics to Present at the 24th Annual ROTH Capital Growth Conference

  3/7/2012

• EnteroMedics to Participate in 4th Annual Lazard Capital Markets Medical Technology Conference

  2/21/2012